Sino Biopharmaceutical Ltd

Sino Biopharmaceutical Ltd, shortly Sino Biopharm, is the first business that is listed among the leading biotech companies in Hong Kong. It is a civilian-run enterprise with a range of subsidiaries, which specializes in the therapeutic areas of oncology, hepatology and respiratory and surgery. This company operates as a research and development pharmaceutical corporation. These subsidiaries are situated in Beijing, Shanghai, Nanjing, Lianyungang, Qingdao as well as other places, and have multiple manufacturing locations.

As a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm has strong producing capabilities and broad patients access across China. It principally takes part in researching, developing, manufacturing and selling biopharmaceutical products for the medical treatment. There are a lot of diseases that these biopharmaceutical products are used to prescribe a treatment like ophthalmia, hepatitis... Moreover, it also participates in other minor businesses through its branches, such as properties, health food, optical glass, optical and auditory products.

Sino Biopharm is committed to innovating to address unmet healthcare demands worldwide. It has been listed in the "Top 50 Global Pharmaceutical Enterprises" announced by the authoritative American magazine Pharmaceutical Director for four successive years. Besides, it also has been ranked as the "Top 50 Best Companies in Asia Pacific" by Forbes (Asia) for three consecutive years.

Founded: 2000

Headquarters: Wan Chai, Hong Kong

Website: https://www.sinobiopharm.com/en/